Scientists have demonstrated RNA polymerase can read eight genetic letters. This enzyme accurately transcribes synthetic DNA, which nature ...

The state of Karnataka is joining forces with New South Wales in Australia to bolster their innovation ecosystems. This agreement will faci...

Jharkhand Health Department is on high alert for potential H1N1 cases. Health Minister Irfan Ansari directed enhanced surveillance and hosp...

Even if the ongoing conflict in the Gulf settles anytime soon (and we certainly hope it does), don’t be surprised if the Nifty and Sensex r...

Launched in 2023, the programme seeks to strengthen collaboration between India and the UK in health innovation and help Indian companies p...

Stock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...

Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...

In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...

New Jersey high schooler Edward Kang, 17, developed RetinaMind, an AI tool that analyzes retinal images to identify patterns linked to auti...

India’s AI healthcare push faces a critical choice: use technology mainly to streamline existing healthcare transactions or build a prevent...

Invesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...

Looking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...

Sometimes the real market story is not in the headline index. The Nifty and Sensex can be under pressure, and yet, below them, mid- and sma...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Will be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.

From AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...

Artificial intelligence is transforming industries with independent reasoning and complex workflow orchestration. New AI products are drivi...